MARKET

SANA

SANA

Sana Biotechnology, Inc.
NASDAQ
3.420
+0.160
+4.91%
After Hours: 3.420 0 0.00% 19:59 06/26 EDT
OPEN
3.230
PREV CLOSE
3.260
HIGH
3.550
LOW
3.230
VOLUME
10.37M
TURNOVER
--
52 WEEK HIGH
6.55
52 WEEK LOW
2.580
MARKET CAP
951.76M
P/E (TTM)
-3.6433
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SANA last week (0615-0619)?
Weekly Report · 6d ago
Weekly Report: what happened at SANA last week (0608-0612)?
Weekly Report · 06/15 09:22
Harbour BioMed appoints Sana Biotechnology CSO Dhavalkumar Patel as scientific advisor
PUBT · 06/12 01:19
As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation?
Seeking Alpha · 06/10 19:19
Weekly Report: what happened at SANA last week (0601-0605)?
Weekly Report · 06/08 09:21
Sana Biotechnology Shareholders Reelect Directors and Ratify Auditor
TipRanks · 06/05 21:02
Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PR Newswire · 06/02 22:11
These 10 small-cap U.S. healthcare companies carry the market's most expensive valuations
Seeking Alpha · 06/02 14:20
More
About SANA
Sana Biotechnology, Inc. is a biotechnology company focusing on utilizing engineered cells as medicines. It is engaged in developing ex vivo and in vivo cell engineering platforms to revolutionize treatment across an array of therapeutic areas with unmet treatment needs, including type 1 diabetes (T1D), oncology, and B cell mediated autoimmune diseases. It develops a pipeline of clinical product candidates focused on creating transformative ex vivo therapies across a range of therapeutic areas. Its pipeline products include SC451 and UP421. SC451 is its HIP-edited product candidate for the treatment of type 1 diabetes. SC451 is a pluripotent stem cell (PSC)-derived hypoimmune pancreatic islet cell product candidate for the treatment of diabetes, with an initial focus on T1D. Its ex vivo cell engineering platform is focused on engineering hypoimmune cells that engraft, function, and persist in patients by evading immune rejection.

Webull offers Sana Biotechnology Inc stock information, including NASDAQ: SANA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SANA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SANA stock methods without spending real money on the virtual paper trading platform.